ELZA’s Cross-Linking Press coverage

Second-generation sub400 cross-linking for ultra-thin keratoconus corneas published

ELZA researchers report 12-month outcomes for a second-generation sub400 cross-linking protocol that extends CXL to ultra-thin keratoconus and post-LASIK ectasia corneas below 400 micrometres, halting progression in 76% of eyes while shortening treatment to about 18 minutes.

READ

Categories: Farhad Hafezi | Nikki Hafezi | Podium Power

ELZA’s CEO and CMO to present at SSCRS 2026 in Jeddah

The ELZA Institute heads to Jeddah for the first SSCRS congress, 24–26 September 2026. Prof. Farhad Hafezi and Nikki Hafezi present four talks spanning personalised cross-linking, epi-on CXL, corneal biomechanics and ELZA-PACE.

READ

Categories: Farhad Hafezi | Mark Hillen | News | Scientific article

ELZA and the Second Global Consensus on Keratoconus and Ectatic Diseases

The Second Global Consensus on Keratoconus and Ectatic Diseases was published today, and ELZA played a key role in its development.

READ

Categories: Emilio Torres | Farhad Hafezi | News | Podium Power

World Keratoconus Congress 2026 in Florence

Insights from ELZA’s contributions to the World Keratoconus Congress 2026 in Florence – ELZA PACE, CXL innovation, and personalised keratoconus treatment strategies